Related Experiment Video
Updated: Jan 26, 2026

Author Spotlight: Deciphering the Role of ATM in Ataxia-Telangiectasia and the Associated Cerebellar Degeneration
Published on: December 27, 2024
CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation
Malgorzata Krajewska1,2, Ruben Dries1,2,3, Andrew V Grassetti4
1Department of Pediatric Hematology/Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, 02115, USA.
Abstract:
Cyclin-dependent kinase 12 (CDK12) modulates transcription elongation by phosphorylating the carboxy-terminal domain of RNA polymerase II and selectively affects the expression of genes involved in the DNA damage response (DDR) and mRNA processing. Yet, the mechanisms underlying such selectivity remain unclear. Here we show that CDK12 inhibition in cancer cells lacking CDK12 mutations results in gene length-dependent elongation defects, inducing premature cleavage and polyadenylation (PCPA) and loss of expression of long (>45 kb) genes, a substantial proportion of which participate in the DDR. This early termination phenotype correlates with an increased number of intronic polyadenylation sites, a feature especially prominent among DDR genes. Phosphoproteomic analysis indicated that CDK12 directly phosphorylates pre-mRNA processing factors, including those regulating PCPA. These results support a model in which DDR genes are uniquely susceptible to CDK12 inhibition primarily due to their relatively longer lengths and lower ratios of U1 snRNP binding to intronic polyadenylation sites.
Insights
Cyclin-dependent kinase 12 (CDK12) inhibition affects long DNA damage response (DDR) genes by causing premature transcription termination. This occurs due to increased intronic polyadenylation sites, impacting gene expression.
Area of Science:
- Molecular Biology
- Cancer Genomics
Background:
- Cyclin-dependent kinase 12 (CDK12) regulates transcription elongation via RNA polymerase II phosphorylation.
- CDK12 influences DNA damage response (DDR) and mRNA processing genes, but its selectivity mechanisms are unclear.
Purpose of the Study:
- To elucidate the mechanisms behind CDK12's selective regulation of gene expression, particularly in cancer cells.
- To investigate the impact of CDK12 inhibition on gene length and the DNA damage response.
Main Methods:
- Utilized CDK12 inhibition in cancer cells lacking CDK12 mutations.
- Analyzed gene length-dependent elongation defects and premature cleavage and polyadenylation (PCPA).
- Performed phosphoproteomic analysis of pre-mRNA processing factors.
Main Results:
- CDK12 inhibition caused gene length-dependent elongation defects, specifically affecting long (>45 kb) genes.
- A significant proportion of affected long genes were involved in the DDR.
- Increased intronic polyadenylation sites were observed, particularly in DDR genes, correlating with early termination.
Conclusions:
- CDK12 inhibition leads to premature termination of long genes, especially DDR genes, through increased intronic polyadenylation.
- DDR genes are uniquely vulnerable to CDK12 inhibition due to their length and specific RNA processing factor ratios.
- CDK12 directly phosphorylates pre-mRNA processing factors, linking its kinase activity to PCPA regulation.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Overview of DNA Repair
Chemically...
Cleavage and Blastulation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Gene Conversion

